For the year ending 2025-12-31, BOLT has $56,748K in assets. $30,243K in debts. $11,703K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 11,703 | |||
| Short-term investments | 15,802 | |||
| Restricted cash | 200 | |||
| Prepaid expenses and other current assets | 2,555 | |||
| Total current assets | 30,260 | |||
| Property and equipment, gross | 8,632 | |||
| Less accumulated depreciation and amortization | 7,387 | |||
| Property and equipment, net | 1,245 | |||
| Operating lease right-of-use assets | 19,230 | |||
| Restricted cash, non-current | 1,538 | |||
| Long-term investments | 4,337 | |||
| Other assets | 138 | |||
| Total assets | 56,748 | |||
| Accounts payable | 1,443 | |||
| Accrued expenses and other current liabilities | 3,717 | |||
| Deferred revenue | 449 | |||
| Operating lease liabilities | 2,826 | |||
| Total current liabilities | 8,435 | |||
| Operating lease liabilities, net of current portion | 20,132 | |||
| Deferred revenue, non-current | 1,544 | |||
| Other long-term liabilities | 132 | |||
| Total liabilities | 30,243 | |||
| Additional paid-in capital | 487,305 | |||
| Accumulated other comprehensive gain | -21 | |||
| Accumulated deficit | -460,779 | |||
| Total stockholders' equity | 26,505 | |||
| Total liabilities and stockholders' equity | 56,748 | |||
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)